Autobahn Therapeutics Announces Successful Financing to Support Strategic Advancement of ABX-002 for Treatment Resistant Depression - Business Wire

Submitted by Anonymous (not verified) on Thu, 09/08/2022 - 12:30

Autobahn Therapeutics Announces Successful Financing to Support Strategic Advancement of ABX-002 for Treatment Resistant Depression  Business Wire